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 HYPOVITAMINOSIS D is common among older adults, affecting up to 90% of the elderly population ( 1 ). This is 
crucial in that results of epidemiological studies suggest that 
hypovitaminosis D is associated with cognitive function and 
Alzheimer ’ s  d isease (AD) ( 2 – 7 ). From a physiological point of 
view, vitamin D is a steroid hormone that exhibits neurosteroid 
actions in the central nervous system ( 8 – 10 ) , and it has been 
proposed that the chronic defi cit of vitamin D neurotrophic, 
anti-infl ammatory as well as antioxidant properties may par-
tially explain neuronal degeneration and AD ( 10 ). 
 Correction of hypovitaminosis D may potentially protect 
older adults against cognitive decline. To date, no randomized 
placebo-controlled trial has explored yet the benefi ts of vita-
min D supplementation to treat or prevent dementia ( 10 ). Prior 
to planning such a resource-consuming supplementation trial, 
considering the contribution of exogenous vitamin D in the diet 
may provide useful information. We recently showed that the 
dietary intakes of vitamin D were directly associated with 
the global cognitive performance in 5,596 women from the 
EPIDemiology of OSteoporosis (EPIDOS) cohort ( 11 ). Our 
study was yet limited by its cross-sectional design that 
prevented establishing the temporal sequence of events. A lon-
gitudinal follow-up remained thus necessary to conclusively 
determine whether low vitamin D dietary intakes precede cog-
nitive decline and the onset of dementia. We had the opportu-
nity to examine this hypothesis in a subgroup of the EPIDOS 
cohort as the cognitive status of participants from one centre, 
Toulouse, was reassessed after  7 years of follow-up ( 12 , 13 ). 
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 Background.  Hypovitaminosis D is associated with cognitive decline among older adults. The relationship between 
vitamin D intakes and cognitive decline is not well understood. Our objective was to determine whether the dietary intake 
of vitamin D was an independent predictor of the onset of dementia within 7 years among women aged 75 years and older. 
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dietary intakes were estimated from self-administered food frequency questionnaire. Age, body mass index, initial cognitive 
performance, education level, physical activity, sun exposure, disability, number of chronic diseases, hypertension, 
depression, use of psychoactive drugs, and baseline season were considered as potential confounders. 
 Results.  Women who developed AD ( n = 70) had lower baseline vitamin D intakes (mean, 50.3  ± 19.3  μ g/wk) than 
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 The objective of this work was to determine whether the 
dietary intake of vitamin D was an independent predictor of 
the onset of dementia (ie, AD or other dementias) among 
older women. 
 M ethods 
 Study  P opulation 
 EPIDOS Study . — The EPIDOS Study was a French , 
large , observational , prospective multicenter cohort study 
designed to evaluate during a 4-year follow-up the risk 
factors for hip fractures among women aged 75 years and 
older. The sampling and data collection procedures have 
been described elsewhere in detail ( 14 ). In summary, from 
1992 to 1994, 7,598  participant s were recruited in fi ve 
French cities from electoral lists (Amiens, Lyon, Montpellier, 
Paris , and Toulouse). Exclusion criteria included inability to 
walk independently, institutionalization, previous history 
of hip fracture or bilateral hip replacement , and inability 
to understand or answer the study questionnaires. All in-
cluded study participants received at baseline a full medical 
examination by trained nurses in each local clinical center, 
which consisted of structured questionnaires, information 
about everyday dietary habits and chronic diseases, and a 
clinical examination. Medications and vitamin supple-
mentation were reported by direct inquiry. Women were 
also asked to bring all the medication, including vitamin D 
supplements, they were regularly taking to the clinical 
centre. 
 Toulouse Cohort Study . — At the end of the EPIDOS 
4-year study, all participants included in the centre of 
Toulouse were invited to take part in an additional 3-year 
follow-up study. The data collection procedures and fl ow 
diagram have been described elsewhere in detail ( 12 ). In 
summary, all women who had given informed consent were 
offered a consultation exactly  7 years after their inclusion. 
They were assessed either at home or at the Department of 
Internal Medicine and Clinical Geriatrics of Toulouse Uni-
versity Hospital. Initially, 1,462 women were included in 
the EPIDOS study in Toulouse. At the end of the 7-year 
follow-up, data on cognitive status (ie, no dementia, AD, or 
other types of dementia) were available for 714 women 
(48.8% of the initial cohort). Of the other 748 women whose 
cognitive status remained undetermined, 193 (25.8%) died 
during follow-up, 414 (54.7%) were lost to follow-up, and 
141 (18.9%) withdrew from the follow-up study ( 12 ). To 
focus solely on the association of dietary intakes of vitamin D 
with cognitive function, women were also excluded 
from the present analysis when they had taken vitamin D 
supplements within the 18 months preceding the baseline 
assessment ( n  =  111). Finally, full clinical data were available 
for 498 women who met the inclusion criteria. 
 Dependent Variable: Cognitive status after seven years of 
follow-up 
 At the seventh year of follow-up, cognitive status was 
assessed during a single standardized interview using the Mini-
Mental State Examination ( 15 ) and the Grober and Buschke 
( 16 ). The diagnosis of dementia was established in a double-
blind manner with the same standardized method of testing 
by a geriatrician and a neurologist from Toulouse University 
Hospital, France, who had expertise in dementia. This method 
has shown excellent interrater agreement, with a kappa score 
close to 1 ( 17 ). Clinical suspicion of dementia was diagnosed 
using the Diagnostic and Statistical Manual of Mental 
Disorders, fourth edition, criteria ( 18 ). Probable or possible 
AD was diagnosed according to the criteria of the National 
Institute of Neurological and Communicative Disorders/
Alzheimer ’ s Disease and Related Disorders Association 
working group ( 19 ). Computed tomography reports or the 
images themselves, when available, were reviewed to rule out 
reversible causes of dementia or contribute to the diagnosis of 
dementia subtypes (ie, cortical and subcortical atrophy or 
infarcts, intracerebral lesions [tumors or hematomas], white 
matter lesions, and presence of enlarged ventricles). Partici-
pants were then classifi ed into three groups: nondemented 
subjects (ND), AD, and other dementias (OD). 
 Explanatory variable: Weekly dietary intakes of vitamin D 
 The baseline vitamin D dietary intakes of all partici-
pants were estimated from a modified Fardellone self-
administered food frequency questionnaire ( 20 ). The 
21-question food frequency questionnaire included  two 
seafood items (lean fi sh [fresh, canning , or frozen], fat fi sh 
 [ herring, anchovy, salmon, sardine, cod liver, mackerel ] ) and 
 six dairy items (milk, cream and yoghurt desserts, cream 
cheese, baked cheese, soft cheese). Other questions inquired 
about eggs, fruits and vegetables, starchy foods, chocolate, 
drinking , and meat products that were used in the computa-
tion of vitamin D intake. The dietary intakes of vitamin D in 
 μ g/wk were obtained by multiplying the content of indi-
vidual food items by the frequency of consumption and 
summing over all items (to convert to international units per 
week, multiply by 40). Vitamin D content of individual food 
items was based on the CIQUAL Database, which is contin-
ually updated by the French food safety agency ( 21 ). This 
variable has already been used to address the cross-sectional 
association with global cognitive performance ( 11 ). Finally, 
dietary intakes of vitamin D were sorted in increasing order 
and categorized into quintiles to evaluate the highest (ie, fi fth) 
quintile ’ s ability to prevent the onset of AD within  7 years. 
 Potential confounders 
 The following confounders were measured at baseline 
assessment: age, body mass index (in kg/m 2 ), initial cogni-
tive performance, education level, physical activity, sun 
exposure at midday, disability, number of chronic diseases, 
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hypertension, current depression, use of psychoactive drugs 
(ie, benzodiazepines, antidepressants , or antipsychotics), 
and season of assessment. 
 A specially trained nurse assessed baseline cognitive 
performance using Pfeiffer Short Portable Mental State 
Questionnaire (SPMSQ) ( 22 ). The SPMSQ proved to be a 
sensitive and specifi c screening test for dementia in com-
munity  dwellers ( 22 ) and has already been used to explore 
the association between vitamin D and cognitive perfor-
mance ( 11 , 23 ). It consists of a 10-item composite question-
naire with a score ranging from 0 to 10, with 10 representing 
the best performance. Women who obtained at least the El-
ementary School Recognition Certifi cate were considered 
to have a high education level compared  with those who did 
not. Disability was defi ned as Lawton eight-item Instru-
mental Activities of Daily Living score  ≤ 4 ( 11 ). Women 
were also asked whether they participated in a sport or 
physical leisure activity regularly (ie, at least  1 hour a week 
for at least the past month). Additionally,  because skin 
generates vitamin D under the action of solar ultraviolet-B 
radiation ( 1 ) and  because the daily maximum values of 
hourly average ultraviolet-B irradiance occur along midday 
hours ( 24 ), the direct exposure of at least face and hands to 
sunlight between 11  am and 3  pm was sought by asking the 
following standardized question:  “ When weather is nice, 
do you stay more than 15 minutes exposed to the sun (face 
and hands uncovered) between 11  am and 3  pm ? ” and was 
coded as a binary  “ Yes ” versus  “ No ” variable. Evaluation 
of chronic diseases (ie, hypertension, diabetes, dyslipid-
emia, coronary heart disease, chronic obstructive pulmo-
nary disease, peripheral vascular disease, cancer, stroke, 
Parkinson ’ s disease , and depression) was based on self-
report. In particular, information about hypertension and 
depression were obtained from the standardized question: 
 “ Do you currently suffer from hypertension or depression? ” 
 Statistical analysis 
 The  participant s ’ characteristics were summarized using 
means and standard deviations or frequencies and percent-
ages, as appropriate. Normality of data distribution was 
checked using skewness-kurtosis test. First, we checked 
how the subjects included in data analysis differed from the 
EPIDOS Toulouse cohort participants who were lost to 
follow-up or not included. Between-group comparisons 
were performed using the independent samples  t  test or the 
 c hi-square test, as appropriate. Second, comparisons between 
participants separated into three groups based on cogni-
tive status at  7 years (ie, ND, AD, or OD) were performed 
using the  c hi-square test or the oneway analysis of variance, 
as appropriate. Further post  hoc analyses were performed 
using Fisher Least Significant Difference test. Third, two 
fully adjusted logistic regression models were used to 
examine the association of the baseline dietary intakes of 
vitamin D (independent variable) with the onset of AD during 
the follow-up, and with the onset of OD (dependent vari-
ables), while taking baseline characteristics into account. 
Analyzes were conducted separately for each model. Finally, 
univariate and multiple logistic regression models (ie, fully 
adjusted model and stepwise backward method) were used 
to examine the association between belonging to the highest 
quintile of vitamin D dietary intakes at baseline assessment 
(independent variable) and developing AD during the 7-year 
follow-up (dependent variable).  p  v alues less than .05 were 
considered signifi cant. Statistical analyses were performed 
with the use of the STATA software (version 11.0;  Stat 
Corp,  College Station,  TX). 
 Ethics 
 Women participating in the study were included after 
having given their written informed consent for research. 
The study was conducted in accordance with the ethical 
standards set forth in the Helsinki Declaration (1983). The 
study protocol was approved by the local Ethical Committee. 
 R esults 
 The women included in data analysis ( n  =  498) were 
signifi cantly younger than the other participants of the 
EPIDOS Toulouse cohort, had a better SPMSQ score at 
baseline, were less often disabled, and practiced exercise 
more often, with more frequent sun exposure at midday 
( Table 1 ). There were no signifi cant differences for the other 
clinical characteristics, especially regarding vitamin D 
dietary intakes. The mean baseline dietary intake of vitamin 
D was 58.41  ±  30.09  μ g/wk (range 2.53 – 205.54). Ninety-eight 
women (mean age 78.7  ±  3.4  years) were in the highest 
quintile of vitamin D dietary intakes (range 77.72 – 205.54 
 μ g/wk; mean 104.38  ±  27.7  μ g/wk). 
 As indicated in  Table 2 , 361 women (72.5%) were nonde-
mented at the end of the follow-up, 70 (14.1%) presented 
with AD, and 67 (13.4%) with OD. Women who developed 
AD had lower baseline vitamin D intakes (mean, 50.3  ± 
 19.3  μ g/wk) than nondemented (mean, 59.0  ±  29.9  μ g/wk) 
or those who developed OD (mean, 63.6  ±  38.1  μ g/wk). 
Women with ND were also younger and had better initial 
cognitive performance compared  with AD and OD ( Table 2 ). 
Finally, women who developed AD were more often disabled 
at baseline than those with ND and were less exposed to 
sun than those with ND or OD. There were no signifi cant 
differences for the other clinical characteristics ( Table 2 ). 
 Table 3 shows multiple logistic regressions for AD or 
OD, with dietary intakes of vitamin D and baseline character-
istics as explanatory variables. Dietary intakes of vitamin D 
were inversely associated with AD (odds ratio  [ OR ]  =  0.99, 
95% confi dence interval [95%  CI]:  0.98 – 0.99), but not with 
OD. Advance in age was directly associated with OD 
(OR  =  1.11, 95%  CI:  1.03 – 1.19), wh ereas the initial cognitive 
performance was inversely associated with AD (OR  =  0.69, 
95%  CI:  0.57 – 0.84) and OD (adjusted OR  =  0.79, 95% 
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(ie, benzodiazepines, antidepressants , or antipsychotics), 
and season of assessment. 
 A specially trained nurse assessed baseline cognitive 
performance using Pfeiffer Short Portable Mental State 
Questionnaire (SPMSQ) ( 22 ). The SPMSQ proved to be a 
sensitive and specifi c screening test for dementia in com-
munity  dwellers ( 22 ) and has already been used to explore 
the association between vitamin D and cognitive perfor-
mance ( 11 , 23 ). It consists of a 10-item composite question-
naire with a score ranging from 0 to 10, with 10 representing 
the best performance. Women who obtained at least the El-
ementary School Recognition Certifi cate were considered 
to have a high education level compared  with those who did 
not. Disability was defi ned as Lawton eight-item Instru-
mental Activities of Daily Living score  ≤ 4 ( 11 ). Women 
were also asked whether they participated in a sport or 
physical leisure activity regularly (ie, at least  1 hour a week 
for at least the past month). Additionally,  because skin 
generates vitamin D under the action of solar ultraviolet-B 
radiation ( 1 ) and  because the daily maximum values of 
hourly average ultraviolet-B irradiance occur along midday 
hours ( 24 ), the direct exposure of at least face and hands to 
sunlight between 11  am and 3  pm was sought by asking the 
following standardized question:  “ When weather is nice, 
do you stay more than 15 minutes exposed to the sun (face 
and hands uncovered) between 11  am and 3  pm ? ” and was 
coded as a binary  “ Yes ” versus  “ No ” variable. Evaluation 
of chronic diseases (ie, hypertension, diabetes, dyslipid-
emia, coronary heart disease, chronic obstructive pulmo-
nary disease, peripheral vascular disease, cancer, stroke, 
Parkinson ’ s disease , and depression) was based on self-
report. In particular, information about hypertension and 
depression were obtained from the standardized question: 
 “ Do you currently suffer from hypertension or depression? ” 
 Statistical analysis 
 The  participant s ’ characteristics were summarized using 
means and standard deviations or frequencies and percent-
ages, as appropriate. Normality of data distribution was 
checked using skewness-kurtosis test. First, we checked 
how the subjects included in data analysis differed from the 
EPIDOS Toulouse cohort participants who were lost to 
follow-up or not included. Between-group comparisons 
were performed using the independent samples  t  test or the 
 c hi-square test, as appropriate. Second, comparisons between 
participants separated into three groups based on cogni-
tive status at  7 years (ie, ND, AD, or OD) were performed 
using the  c hi-square test or the oneway analysis of variance, 
as appropriate. Further post  hoc analyses were performed 
using Fisher Least Significant Difference test. Third, two 
fully adjusted logistic regression models were used to 
examine the association of the baseline dietary intakes of 
vitamin D (independent variable) with the onset of AD during 
the follow-up, and with the onset of OD (dependent vari-
ables), while taking baseline characteristics into account. 
Analyzes were conducted separately for each model. Finally, 
univariate and multiple logistic regression models (ie, fully 
adjusted model and stepwise backward method) were used 
to examine the association between belonging to the highest 
quintile of vitamin D dietary intakes at baseline assessment 
(independent variable) and developing AD during the 7-year 
follow-up (dependent variable).  p  v alues less than .05 were 
considered signifi cant. Statistical analyses were performed 
with the use of the STATA software (version 11.0;  Stat 
Corp,  College Station,  TX). 
 Ethics 
 Women participating in the study were included after 
having given their written informed consent for research. 
The study was conducted in accordance with the ethical 
standards set forth in the Helsinki Declaration (1983). The 
study protocol was approved by the local Ethical Committee. 
 R esults 
 The women included in data analysis ( n  =  498) were 
signifi cantly younger than the other participants of the 
EPIDOS Toulouse cohort, had a better SPMSQ score at 
baseline, were less often disabled, and practiced exercise 
more often, with more frequent sun exposure at midday 
( Table 1 ). There were no signifi cant differences for the other 
clinical characteristics, especially regarding vitamin D 
dietary intakes. The mean baseline dietary intake of vitamin 
D was 58.41  ±  30.09  μ g/wk (range 2.53 – 205.54). Ninety-eight 
women (mean age 78.7  ±  3.4  years) were in the highest 
quintile of vitamin D dietary intakes (range 77.72 – 205.54 
 μ g/wk; mean 104.38  ±  27.7  μ g/wk). 
 As indicated in  Table 2 , 361 women (72.5%) were nonde-
mented at the end of the follow-up, 70 (14.1%) presented 
with AD, and 67 (13.4%) with OD. Women who developed 
AD had lower baseline vitamin D intakes (mean, 50.3  ± 
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or those who developed OD (mean, 63.6  ±  38.1  μ g/wk). 
Women with ND were also younger and had better initial 
cognitive performance compared  with AD and OD ( Table 2 ). 
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 CI:  0.65 – 0.96), and sun exposure at midday was inversely 
associated with AD (adjusted OR  =  0.46, 95%  CI:  0.25 – 0.86 ; 
 Table 3 ). 
 Fewer women presented with AD within the highest 
quintile of vitamin D dietary intakes compared  with the 
lower 4 quintiles combined (4.1% v s 16.7%, respectively; 
 p  =  .001).  Table 4 reports the univariate and multiple logistic 
regressions between developing AD within  7 years and 
belonging to the highest quintile of vitamin D dietary intakes 
at baseline evaluation compared  with the other 4 quintiles 
combined. Highest dietary intakes of vitamin D were associ-
ated with a lower risk of AD after the 7-year follow-up 
(unadjusted  OR  =  0.21, 95%  CI:  0.08 – 0.60), even after 
 adjustment for confounders (adjusted  OR  =  0.23, 95% 
 CI:  0.08 – 0.69) and also in the stepwise backward model 
(adjusted  OR  =  0.23, 95%  CI:  0.08 – 0.67 ;  Table 4 ). Further-
more, initial cognitive performance and sun exposure at 
midday were signifi cantly associated with a lower risk of 
AD ( Table 4 ). 
 D iscussion 
 The main fi nding of this prospectively  followed cohort 
study of 498 older women initially free of vitamin D sup-
plements was that the baseline dietary intake of vitamin D 
was inversely associated with the onset of AD within 
 7 years. The highest consumption of dietary vitamin D 
was associated with a decreased incidence of AD by 4.35 
times. There was no association between the baseline 
dietary intakes of vitamin D and the onset of OD. 
 Only two previous cross-sectional studies have addressed 
the relationship between dietary vitamin D and cognitive 
performance. The fi rst one highlighted a negative correlation 
between the  3 -day dietary intakes of vitamin D and poor 
 Table 1.  Baseline  C haracteristics of  S ubjects 
 EPIDOS Toulouse Cohort ( n = 1,462) Studied Sample ( n = 498)  p Value* 
 Age, mean  ±  SD (y) 80.64  ± 3.91 79.84  ± 3.80  <.001 
 Body mass index, mean  ±  SD (kg/m 2 ) 25.19  ± 4.00 25.12  ± 4.01 .721 
 Short Portable Mental State 
  Questionnaire score, mean  ±  SD (/10)
8.39  ± 1.99 8.82  ± 1.26  <.001 
 High education level,  n (%) 110 (11.6) 64 (12.9) .410 
 Disability,  n (%) 50 (5.2) 11 (2.2)  .007 
 Regular physical activity,  n (%) 326 (34.0) 215 (43.2)  .001 
 Sun exposure at midday,  n (%) 335 (34.9) 225 (45.4)  <.001 
 Number of chronic diseases, mean  ±  SD 4.25  ± 1.61 4.24  ± 1.78 .947 
 Hypertension,  n (%) 458 (47.8) 236 (47.4) .937 
 Depression,  n (%) 133 (13.9) 57 (11.1) .132 
 Use psychoactive drugs,  n (%) 458 (47.5) 230 (46.2) .737 
 Dietary vitamin D intakes, mean  ±  SD ( μ g/wk) 58.44  ± 26.55 58.41  ± 30.09 .989 
 Note .  p  value signifi cant (ie ,  <.05) indicated in bold. 
 *Based on  t  test or  c hi-square test, as appropriate. 
 Table 2.  Baseline  C haracteristics and  C omparison of the  Participants ( n  =  498)  S eparated  I nto  T hree  G roups  B ased on the  O nset of  D ementia 
 W ithin 7  Y ears 
 Onset of  p Value* 
 
No Dementia (ND), 
 n = 361
Alzheimer’s Disease (AD), 
 n = 70
Other Dementias (OD), 
 n = 67 Overall
ND Versus 
AD
ND Versus 
OD
AD Versus 
OD 
 Age, mean  ±  SD (years) 79.27  ± 3.60 81.38  ± 4.11 81.25  ± 3.78  <.001  < . 001  <.001 .841 
 Body mass index, 
  mean  ±  SD (kg/m 2 )
25.22  ± 4.01 24.73  ± 3.69 24.99  ± 4.39 .959  
 Short Portable Mental State 
  Questionnaire score, 
   mean  ±  SD (/10)
9.05  ± 1.00 8.09  ± 1.54 8.34  ± 1.73  <.001  < . 001  <.001 .212 
 High education level,  n (%) 46 (12.8) 11 (15.7) 7 (10.4) .652  
 Disability,  n (%) 3 (0.8) 6 (8.6) 2 (3.0)  <.001  < . 001 .132 .163 
 Regular physical activity,  n (%) 165 (45.7) 24 (34.3) 26 (38.8) .156  
 Sun exposure at midday,  n (%) 178 (49.3) 18 (25.7) 30 (44.8)  <.001  < . 001 .496  .019 
 Number of chronic diseases, 
  mean  ±  SD 
4.17  ± 1.53 4.40  ± 1.55 4.45  ± 2.92 .374  
 Hypertension,  n (%) 171 (47.4) 32 (45.7) 33 (49.3) .917  
 Depression,  n (%) 39 (10.8) 10 (14.3) 8 (11.9) .703  
 Use psychoactive drugs,  n (%) 161 (44.6) 38 (54.3) 31 (46.3) .331  
 Dietary vitamin D intakes, 
  mean  ±  SD ( μ g/wk)
59.00  ± 29.90 50.33  ± 19.32 63.62  ± 38.12  .027  .027 .247  .010 
 Notes :  p value signifi cant (ie, <.05) indicated in bold. 
 *Comparisons based on  c hi-square test or oneway analysis of variance, as appropriate; post  hoc analyses performed using Fisher Least Signifi cant Difference test . 
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performance on Mini-Mental State Examination ( r  =  .35, 
 p  <  .01) among 69 community-dwelling elderly  participants 
 ( 25 ). The second study, by our team, showed among 5,596 
community-dwelling older women free of vitamin D sup-
plements from the EPIDOS study, that the weekly dietary 
intakes of vitamin D were cross-sectionally associated with 
the global cognitive performance measured with SPMSQ 
( β  =  .002,  p  <  .001) ( 11 ). Our previous results additionally 
stressed that low weekly vitamin D dietary intakes were 
associated with cognitive impairment (OR  =  1.30,  p  =  .024) 
( 11 ). Compared  with the present study, both these works 
were cross-sectional, which precluded determining whether 
cognitive decline precipitated low consumption of dietary 
vitamin D due to disability-induced undernutrition or 
whether low dietary intakes of vitamin D had a role in pre-
cipitating cognitive decline. To the best of our knowledge, 
the present study is the fi rst one to use a prospective design, 
allowing us to conclude that the low consumption of vitamin D 
precedes the onset of AD, although eating lots of vitamin D 
rich foods is associated with a lower risk of developing AD. 
 AD is a neurodegenerative disease characterized by senile 
plaques consistent with extracellular accumulation of A β 42 
peptide and by hyperphosphorylation of TAU proteins that 
leads to neurofi brillary tangles ( 26 ). Taken together, these 
 Table 3.  Logistic  R egression  S howing the  A ssociation  B etween the  D ietary  V itamin D  I ntakes at  B aseline (independent variable) and the  O nset 
of  D ementia  W ithin 7  Y ears (dependent variable)*  A djusted for  Participants’  B aseline  C haracteristics  †  ( n  =  498) 
 Type of Dementia* 
 Onset of Alzheimer ’ s Disease Onset of Other Dementias 
 Adjusted OR (95% CI)  p Value Adjusted OR (95% CI)  p Value 
 Dietary vitamin D intakes ( μ g/wk)  0 . 99 ( 0 . 98 – 0 . 99) . 041 1.01 (1.00 – 1.02) .071 
 Age 1.04 (0.97 – 1.12) .251  1 . 11 ( 1 . 03 – 1 . 19) . 005 
 Body mass index 0.95 (0.88 – 1.03) .223 1.01 (0.94 – 1.08) .825 
 Short Portable Mental State 
  Questionnaire score
 0 . 69 ( 0 . 57 – 0 . 84)  < . 001  0 . 79 ( 0 . 65 – 0 . 96) . 016 
 High education level 1.09 (0.50 – 2.37) .839 0.78 (0.33 – 1.86) .576 
 Disability 2.24 (0.57-8.86) .249 0.50 (0.08 – 3.03) .448 
 Regular physical activity 0.79 (0.44-1.42) .433 0.83 (0.47-1.46) .516 
 Sun exposure at midday  0 . 46 ( 0 . 25 – 0 . 86) . 015 1.19 (0.67 – 2.10) .551 
 Number of chronic diseases 1.08 (0.91 – 1.28) .373 1.05 (0.90 – 1.21) .552 
 Hypertension 0.70 (0.38 – 1.29) .256 1.01 (0.56 – 1.80) .998 
 Depression 0.94 (0.40 – 2.19) .877 0.99 (0.41 – 2.37) .975 
 Use psychoactive drugs 1.18 (0.67 – 2.10) .567 1.07 (0.61 – 1.86) .823 
 Notes: CI = confi dence interval;  OR =  o dds  r atio; odds ratio signifi cant (ie,  p < .05) indicated in bold . 
 *Two different regression models were used to predict the occurrence of Alzheimer ’ s disease and other dementias . 
 
 † 
  Including the infl uence of season at baseline, with no signifi cant association with the onset of AD ( p  =  .350) and OD ( p  =  .769). 
 Table 4.  Univariate and  M ultiple  L ogistic  R egressions  S howing the  A ssociation  B etween  B elonging to the  H ighest  Q uintile of  V itamin D 
 D ietary  I ntakes at  B aseline  A ssessment (independent variable) and  D eveloping Alzheimer ’ s  D isease  W ithin 7  Y ears (dependent variable), 
 A djusted for Participants’  B aseline  C haracteristics* ( n  =  498) 
 Onset of Alzheimer ’ s Disease 
 Unadjusted Model Fully Adjusted Model Stepwise Backward Model 
 OR 95% CI  p Value OR 95% CI  p Value OR 95% CI  p Value 
 Highest quintile of vitamin 
  D dietary intakes  †  
 0 . 21  0 . 08 – 0 . 60 . 003  0 . 23  0.08 – 0.69  .009  0 . 23  0 . 08 – 0 . 67 . 007 
 Age  1 . 12  1 . 05 – 1 . 19  <.001 1.04 0.97 – 1.12 .291  —  —  — 
 Body mass index 0.97 0.91 – 1.04 .375 0.95 0.88 – 1.03 .221  —  —  — 
 Short Portable Mental State 
  Questionnaire score
 0 . 64  0 . 53 – 0 . 77  < . 001  0 . 69  0 . 57 – 0 . 84  < . 001  0.68  0 . 56 – 0 . 83  < . 001 
 High education level 1.33 0.66 – 2.69 .433 0.99 0.46 – 2.20 .999  —  —  — 
 Disability  7 . 86  2 . 33 – 26 . 49 . 001 2.48 0.63 – 9.80 .194 3.48 0.94 – 12.86 .061 
 Regular physical activity 0.65 0.38 – 1.10 .109 0.84 0.47 – 1.53 .576  —  —  — 
 Sun exposure at midday  0 . 36  0 . 21 – 0 . 64  < . 001  0 . 45  0.24 – 0.85 . 013  0 . 44  0 . 24 – 0 . 80 . 007 
 Number of chronic diseases 1.06 0.93 – 1.20 .422 1.07 0.91 – 1.26 .421  —  —  — 
 Hypertension 0.91 0.55 – 1.51 .710 0.72 0.39 – 1.32 .289  —  —  — 
 Depression 1.40 0.67 – 2.93 .371 0.91 0.39 – 2.14 .831  —  —  — 
 Use psychoactive drugs 1.48 0.89 – 2.45 .133 1.16 0.65 – 2.06 .615  —  —  — 
 Notes: CI = confi dence interval;  OR =  o dds  r atio; odds ratio signifi cant (ie, p < .05) indicated in bold . 
 *  Including the infl uence of season at baseline, with no signifi cant effect ( p  =  .291) 
 † Highest quintile v ersu s lowest 4 quintiles combined. 
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 CI:  0.65 – 0.96), and sun exposure at midday was inversely 
associated with AD (adjusted OR  =  0.46, 95%  CI:  0.25 – 0.86 ; 
 Table 3 ). 
 Fewer women presented with AD within the highest 
quintile of vitamin D dietary intakes compared  with the 
lower 4 quintiles combined (4.1% v s 16.7%, respectively; 
 p  =  .001).  Table 4 reports the univariate and multiple logistic 
regressions between developing AD within  7 years and 
belonging to the highest quintile of vitamin D dietary intakes 
at baseline evaluation compared  with the other 4 quintiles 
combined. Highest dietary intakes of vitamin D were associ-
ated with a lower risk of AD after the 7-year follow-up 
(unadjusted  OR  =  0.21, 95%  CI:  0.08 – 0.60), even after 
 adjustment for confounders (adjusted  OR  =  0.23, 95% 
 CI:  0.08 – 0.69) and also in the stepwise backward model 
(adjusted  OR  =  0.23, 95%  CI:  0.08 – 0.67 ;  Table 4 ). Further-
more, initial cognitive performance and sun exposure at 
midday were signifi cantly associated with a lower risk of 
AD ( Table 4 ). 
 D iscussion 
 The main fi nding of this prospectively  followed cohort 
study of 498 older women initially free of vitamin D sup-
plements was that the baseline dietary intake of vitamin D 
was inversely associated with the onset of AD within 
 7 years. The highest consumption of dietary vitamin D 
was associated with a decreased incidence of AD by 4.35 
times. There was no association between the baseline 
dietary intakes of vitamin D and the onset of OD. 
 Only two previous cross-sectional studies have addressed 
the relationship between dietary vitamin D and cognitive 
performance. The fi rst one highlighted a negative correlation 
between the  3 -day dietary intakes of vitamin D and poor 
 Table 1.  Baseline  C haracteristics of  S ubjects 
 EPIDOS Toulouse Cohort ( n = 1,462) Studied Sample ( n = 498)  p Value* 
 Age, mean  ±  SD (y) 80.64  ± 3.91 79.84  ± 3.80  <.001 
 Body mass index, mean  ±  SD (kg/m 2 ) 25.19  ± 4.00 25.12  ± 4.01 .721 
 Short Portable Mental State 
  Questionnaire score, mean  ±  SD (/10)
8.39  ± 1.99 8.82  ± 1.26  <.001 
 High education level,  n (%) 110 (11.6) 64 (12.9) .410 
 Disability,  n (%) 50 (5.2) 11 (2.2)  .007 
 Regular physical activity,  n (%) 326 (34.0) 215 (43.2)  .001 
 Sun exposure at midday,  n (%) 335 (34.9) 225 (45.4)  <.001 
 Number of chronic diseases, mean  ±  SD 4.25  ± 1.61 4.24  ± 1.78 .947 
 Hypertension,  n (%) 458 (47.8) 236 (47.4) .937 
 Depression,  n (%) 133 (13.9) 57 (11.1) .132 
 Use psychoactive drugs,  n (%) 458 (47.5) 230 (46.2) .737 
 Dietary vitamin D intakes, mean  ±  SD ( μ g/wk) 58.44  ± 26.55 58.41  ± 30.09 .989 
 Note .  p  value signifi cant (ie ,  <.05) indicated in bold. 
 *Based on  t  test or  c hi-square test, as appropriate. 
 Table 2.  Baseline  C haracteristics and  C omparison of the  Participants ( n  =  498)  S eparated  I nto  T hree  G roups  B ased on the  O nset of  D ementia 
 W ithin 7  Y ears 
 Onset of  p Value* 
 
No Dementia (ND), 
 n = 361
Alzheimer’s Disease (AD), 
 n = 70
Other Dementias (OD), 
 n = 67 Overall
ND Versus 
AD
ND Versus 
OD
AD Versus 
OD 
 Age, mean  ±  SD (years) 79.27  ± 3.60 81.38  ± 4.11 81.25  ± 3.78  <.001  < . 001  <.001 .841 
 Body mass index, 
  mean  ±  SD (kg/m 2 )
25.22  ± 4.01 24.73  ± 3.69 24.99  ± 4.39 .959  
 Short Portable Mental State 
  Questionnaire score, 
   mean  ±  SD (/10)
9.05  ± 1.00 8.09  ± 1.54 8.34  ± 1.73  <.001  < . 001  <.001 .212 
 High education level,  n (%) 46 (12.8) 11 (15.7) 7 (10.4) .652  
 Disability,  n (%) 3 (0.8) 6 (8.6) 2 (3.0)  <.001  < . 001 .132 .163 
 Regular physical activity,  n (%) 165 (45.7) 24 (34.3) 26 (38.8) .156  
 Sun exposure at midday,  n (%) 178 (49.3) 18 (25.7) 30 (44.8)  <.001  < . 001 .496  .019 
 Number of chronic diseases, 
  mean  ±  SD 
4.17  ± 1.53 4.40  ± 1.55 4.45  ± 2.92 .374  
 Hypertension,  n (%) 171 (47.4) 32 (45.7) 33 (49.3) .917  
 Depression,  n (%) 39 (10.8) 10 (14.3) 8 (11.9) .703  
 Use psychoactive drugs,  n (%) 161 (44.6) 38 (54.3) 31 (46.3) .331  
 Dietary vitamin D intakes, 
  mean  ±  SD ( μ g/wk)
59.00  ± 29.90 50.33  ± 19.32 63.62  ± 38.12  .027  .027 .247  .010 
 Notes :  p value signifi cant (ie, <.05) indicated in bold. 
 *Comparisons based on  c hi-square test or oneway analysis of variance, as appropriate; post  hoc analyses performed using Fisher Least Signifi cant Difference test . 
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performance on Mini-Mental State Examination ( r  =  .35, 
 p  <  .01) among 69 community-dwelling elderly  participants 
 ( 25 ). The second study, by our team, showed among 5,596 
community-dwelling older women free of vitamin D sup-
plements from the EPIDOS study, that the weekly dietary 
intakes of vitamin D were cross-sectionally associated with 
the global cognitive performance measured with SPMSQ 
( β  =  .002,  p  <  .001) ( 11 ). Our previous results additionally 
stressed that low weekly vitamin D dietary intakes were 
associated with cognitive impairment (OR  =  1.30,  p  =  .024) 
( 11 ). Compared  with the present study, both these works 
were cross-sectional, which precluded determining whether 
cognitive decline precipitated low consumption of dietary 
vitamin D due to disability-induced undernutrition or 
whether low dietary intakes of vitamin D had a role in pre-
cipitating cognitive decline. To the best of our knowledge, 
the present study is the fi rst one to use a prospective design, 
allowing us to conclude that the low consumption of vitamin D 
precedes the onset of AD, although eating lots of vitamin D 
rich foods is associated with a lower risk of developing AD. 
 AD is a neurodegenerative disease characterized by senile 
plaques consistent with extracellular accumulation of A β 42 
peptide and by hyperphosphorylation of TAU proteins that 
leads to neurofi brillary tangles ( 26 ). Taken together, these 
 Table 3.  Logistic  R egression  S howing the  A ssociation  B etween the  D ietary  V itamin D  I ntakes at  B aseline (independent variable) and the  O nset 
of  D ementia  W ithin 7  Y ears (dependent variable)*  A djusted for  Participants’  B aseline  C haracteristics  †  ( n  =  498) 
 Type of Dementia* 
 Onset of Alzheimer ’ s Disease Onset of Other Dementias 
 Adjusted OR (95% CI)  p Value Adjusted OR (95% CI)  p Value 
 Dietary vitamin D intakes ( μ g/wk)  0 . 99 ( 0 . 98 – 0 . 99) . 041 1.01 (1.00 – 1.02) .071 
 Age 1.04 (0.97 – 1.12) .251  1 . 11 ( 1 . 03 – 1 . 19) . 005 
 Body mass index 0.95 (0.88 – 1.03) .223 1.01 (0.94 – 1.08) .825 
 Short Portable Mental State 
  Questionnaire score
 0 . 69 ( 0 . 57 – 0 . 84)  < . 001  0 . 79 ( 0 . 65 – 0 . 96) . 016 
 High education level 1.09 (0.50 – 2.37) .839 0.78 (0.33 – 1.86) .576 
 Disability 2.24 (0.57-8.86) .249 0.50 (0.08 – 3.03) .448 
 Regular physical activity 0.79 (0.44-1.42) .433 0.83 (0.47-1.46) .516 
 Sun exposure at midday  0 . 46 ( 0 . 25 – 0 . 86) . 015 1.19 (0.67 – 2.10) .551 
 Number of chronic diseases 1.08 (0.91 – 1.28) .373 1.05 (0.90 – 1.21) .552 
 Hypertension 0.70 (0.38 – 1.29) .256 1.01 (0.56 – 1.80) .998 
 Depression 0.94 (0.40 – 2.19) .877 0.99 (0.41 – 2.37) .975 
 Use psychoactive drugs 1.18 (0.67 – 2.10) .567 1.07 (0.61 – 1.86) .823 
 Notes: CI = confi dence interval;  OR =  o dds  r atio; odds ratio signifi cant (ie,  p < .05) indicated in bold . 
 *Two different regression models were used to predict the occurrence of Alzheimer ’ s disease and other dementias . 
 
 † 
  Including the infl uence of season at baseline, with no signifi cant association with the onset of AD ( p  =  .350) and OD ( p  =  .769). 
 Table 4.  Univariate and  M ultiple  L ogistic  R egressions  S howing the  A ssociation  B etween  B elonging to the  H ighest  Q uintile of  V itamin D 
 D ietary  I ntakes at  B aseline  A ssessment (independent variable) and  D eveloping Alzheimer ’ s  D isease  W ithin 7  Y ears (dependent variable), 
 A djusted for Participants’  B aseline  C haracteristics* ( n  =  498) 
 Onset of Alzheimer ’ s Disease 
 Unadjusted Model Fully Adjusted Model Stepwise Backward Model 
 OR 95% CI  p Value OR 95% CI  p Value OR 95% CI  p Value 
 Highest quintile of vitamin 
  D dietary intakes  †  
 0 . 21  0 . 08 – 0 . 60 . 003  0 . 23  0.08 – 0.69  .009  0 . 23  0 . 08 – 0 . 67 . 007 
 Age  1 . 12  1 . 05 – 1 . 19  <.001 1.04 0.97 – 1.12 .291  —  —  — 
 Body mass index 0.97 0.91 – 1.04 .375 0.95 0.88 – 1.03 .221  —  —  — 
 Short Portable Mental State 
  Questionnaire score
 0 . 64  0 . 53 – 0 . 77  < . 001  0 . 69  0 . 57 – 0 . 84  < . 001  0.68  0 . 56 – 0 . 83  < . 001 
 High education level 1.33 0.66 – 2.69 .433 0.99 0.46 – 2.20 .999  —  —  — 
 Disability  7 . 86  2 . 33 – 26 . 49 . 001 2.48 0.63 – 9.80 .194 3.48 0.94 – 12.86 .061 
 Regular physical activity 0.65 0.38 – 1.10 .109 0.84 0.47 – 1.53 .576  —  —  — 
 Sun exposure at midday  0 . 36  0 . 21 – 0 . 64  < . 001  0 . 45  0.24 – 0.85 . 013  0 . 44  0 . 24 – 0 . 80 . 007 
 Number of chronic diseases 1.06 0.93 – 1.20 .422 1.07 0.91 – 1.26 .421  —  —  — 
 Hypertension 0.91 0.55 – 1.51 .710 0.72 0.39 – 1.32 .289  —  —  — 
 Depression 1.40 0.67 – 2.93 .371 0.91 0.39 – 2.14 .831  —  —  — 
 Use psychoactive drugs 1.48 0.89 – 2.45 .133 1.16 0.65 – 2.06 .615  —  —  — 
 Notes: CI = confi dence interval;  OR =  o dds  r atio; odds ratio signifi cant (ie, p < .05) indicated in bold . 
 *  Including the infl uence of season at baseline, with no signifi cant effect ( p  =  .291) 
 † Highest quintile v ersu s lowest 4 quintiles combined. 
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lesions cause infl ammation and oxidative stress involved in 
neuronal death as well as glutamate release with calcium 
neurotoxicity ( 26 ). Current preventive therapeutic strategies 
for AD primarily aim at fi ghting neuronal damages. Precisely, 
vitamin D has demonstrated neuroprotective effects that cur-
rent antidementia drugs do not have ( 8 – 10 ). Experimentally, 
vitamin D reduces hippocampus degenerative processes in 
aging rodents and is involved in detoxifi cation process by 
interacting with reactive oxygen and nitrogen species and 
by regulating the activity of  γ -glutamyl transpeptidase ( 9 ). 
Neuronal survival may also result from vitamin D – related 
intraneuronal calcium homeostasis being maintained via the 
regulation of voltage-dependent calcium channels and via 
the synthesis of calcium-related cytoplasmic proteins such 
as parvalbumine or calbinding protein ( 8 , 10 ). In addition, 
vitamin D could also have an infl uential role in the amelio-
ration of adverse effects in the amyloid hypothesis of AD 
 because it may attenuate A β 42 accumulation by stimulating 
the innate immune system, specifi cally the phagocytosis and 
clearance of amyloid  β -protein ( 10 ). Finally, experimentation 
reported that vitamin D supplementation in rodents resulted 
in an increase in choline acetyltransferase activity (thus an 
increase in acetylcholine availability) in several brain regions 
involved in memory ( 8 ). 
 Alongside vitamin D neurosteroid effects, the association 
of dietary intakes of vitamin D with AD may also be explained 
in a more general way by everyday dietary habits ( 26 , 27 ). In 
particular, there is reasonably good evidence that eating fi sh 
reduces the risk of dementia including AD ( 27 – 30 ). This 
effect is generally attributed to the omega-3 polyunsaturated 
fatty acids ( 27 ) even if data are confl icting. For instance, the 
Rotterdam Study, although having reported a 70% signifi cant 
reduction in risk of AD after a 2 - year follow-up with con-
sumption of one fi shmeal per week ( 28 ), failed to fi nd an 
association between omega-3 fatty acids and the risk of AD 
after a 6-year follow-up ( 29 ). In addition, no clinical trial 
has shown yet a protective effect of fi sh oil supplements on 
cognitive decline ( 27 ). These mixed results strengthen the 
assumption that not only omega-3 acids but also another 
constituent of fatty fi sh — such as vitamin D — could prevent 
dementia ( 30 ). For illustration, women who did not develop 
dementia in our study consumed about 10  μ g/wk of vitamin 
D more than those who developed AD. In a practical sense, this 
corresponds to approximately 115 g (4 oz) of cooked salmon 
or cooked macquerel per week, or 170 g (6 oz) of tuna fi sh 
canned in oil ( 21 , 31 ). Also, the highest quintile of vitamin D 
dietary intakes, which was associated to a lower risk of devel-
oping AD within 7 years, corresponds to the consumption of 
about 50 mL of cod liver oil per week, or 100 g (3.5 oz) 
kipper fi llet per day, or 200 g (7 oz) serving of sardines or 
anchovies canned in oil per day ( 21 , 31 ). 
 We failed to fi nd a signifi cant association between dietary 
vitamin D and the occurrence of non-AD dementias. At fi rst 
sight, this seems to contradict previous literature proposing 
that vitamin D intakes could prevent vascular dementia 
( 32 ). Indeed, vitamin D neurotrophic action is neuroprotec-
tive in the case of cerebral ischemia ( 8 ), and hypovitamino-
sis D may be a vascular risk factor ( 33 ). It has been found 
among 318 older adults (mean age 74 years; 72.6% women) 
that subjects with hypovitaminosis D presented with more 
brain white matter hyperintensities ( p  <  .01) and more vessel 
infarcts ( p  <  .01) than controls ( 5 ). Inconsistencies with our 
study should be explained by the fact that non-AD dementias 
in our study could not be summed up with vascular dementias 
but also included neurosurgical or metabolic mechanisms 
that have no known relationship with vitamin D status. 
 Some limitations of this study need to be considered. 
First, the cohort was restricted to well-functioning women 
who might have easy access to vitamin D – rich foods and 
who might be unrepresentative of the general population of 
older adults. For instance, the mean dietary vitamin D intake of 
58.4  ±  30.1  μ g/wk (range: 2.5 – 205.5) reported in our study 
was relatively high compared  with previous studies reporting a 
mean intake around 40  μ g/wk in older adults with extremes 
values reaching 600  μ g/wk ( 34 , 35 ). Second, limitations of 
the study include the unavailability of a date of diagnosis of 
dementia and the lack of specifi c diagnosis of vascular demen-
tia within the group of OD. Third, an additional limitation 
lied in the self-administration of the food frequency question-
naire that might expose cognitively impaired participants to 
provide unreliable and invalid dietary data ( 20 ). However, 
the exclusion of 74 women with cognitive impairment at 
baseline (ie, SPMSQ score  <  8 ( 22 )) did not alter the mean-
ing and signifi cance of our results (data not shown), revealing 
that the measure of vitamin D dietary intakes was robust. 
Fourth, the interpretation of our results should also account 
for the high percentage of lost to follow-up that reached one 
in two in our study. Finally, in order to provide complemen-
tary information to the growing number of studies examin-
ing the association of serum 25-hydroxyvitamin D (25(OH)
D) concentration with cognitive function ( 2 – 7 ), we chose to 
examine instead the dietary intake of vitamin D, even if it is 
not the only contributor to 25(OH)D concentration. To limit 
confounding bias ( 36 ), we took into account other variables 
participating in 25(OH)D status such as sun exposure, season, 
 body mass index, or age ( 1 ). However residual potential 
confounders, including the variables changes during follow-
up, might still be present. Clinical trials are now warranted 
to explore the effect of vitamin D supplements on AD. 
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lesions cause infl ammation and oxidative stress involved in 
neuronal death as well as glutamate release with calcium 
neurotoxicity ( 26 ). Current preventive therapeutic strategies 
for AD primarily aim at fi ghting neuronal damages. Precisely, 
vitamin D has demonstrated neuroprotective effects that cur-
rent antidementia drugs do not have ( 8 – 10 ). Experimentally, 
vitamin D reduces hippocampus degenerative processes in 
aging rodents and is involved in detoxifi cation process by 
interacting with reactive oxygen and nitrogen species and 
by regulating the activity of  γ -glutamyl transpeptidase ( 9 ). 
Neuronal survival may also result from vitamin D – related 
intraneuronal calcium homeostasis being maintained via the 
regulation of voltage-dependent calcium channels and via 
the synthesis of calcium-related cytoplasmic proteins such 
as parvalbumine or calbinding protein ( 8 , 10 ). In addition, 
vitamin D could also have an infl uential role in the amelio-
ration of adverse effects in the amyloid hypothesis of AD 
 because it may attenuate A β 42 accumulation by stimulating 
the innate immune system, specifi cally the phagocytosis and 
clearance of amyloid  β -protein ( 10 ). Finally, experimentation 
reported that vitamin D supplementation in rodents resulted 
in an increase in choline acetyltransferase activity (thus an 
increase in acetylcholine availability) in several brain regions 
involved in memory ( 8 ). 
 Alongside vitamin D neurosteroid effects, the association 
of dietary intakes of vitamin D with AD may also be explained 
in a more general way by everyday dietary habits ( 26 , 27 ). In 
particular, there is reasonably good evidence that eating fi sh 
reduces the risk of dementia including AD ( 27 – 30 ). This 
effect is generally attributed to the omega-3 polyunsaturated 
fatty acids ( 27 ) even if data are confl icting. For instance, the 
Rotterdam Study, although having reported a 70% signifi cant 
reduction in risk of AD after a 2 - year follow-up with con-
sumption of one fi shmeal per week ( 28 ), failed to fi nd an 
association between omega-3 fatty acids and the risk of AD 
after a 6-year follow-up ( 29 ). In addition, no clinical trial 
has shown yet a protective effect of fi sh oil supplements on 
cognitive decline ( 27 ). These mixed results strengthen the 
assumption that not only omega-3 acids but also another 
constituent of fatty fi sh — such as vitamin D — could prevent 
dementia ( 30 ). For illustration, women who did not develop 
dementia in our study consumed about 10  μ g/wk of vitamin 
D more than those who developed AD. In a practical sense, this 
corresponds to approximately 115 g (4 oz) of cooked salmon 
or cooked macquerel per week, or 170 g (6 oz) of tuna fi sh 
canned in oil ( 21 , 31 ). Also, the highest quintile of vitamin D 
dietary intakes, which was associated to a lower risk of devel-
oping AD within 7 years, corresponds to the consumption of 
about 50 mL of cod liver oil per week, or 100 g (3.5 oz) 
kipper fi llet per day, or 200 g (7 oz) serving of sardines or 
anchovies canned in oil per day ( 21 , 31 ). 
 We failed to fi nd a signifi cant association between dietary 
vitamin D and the occurrence of non-AD dementias. At fi rst 
sight, this seems to contradict previous literature proposing 
that vitamin D intakes could prevent vascular dementia 
( 32 ). Indeed, vitamin D neurotrophic action is neuroprotec-
tive in the case of cerebral ischemia ( 8 ), and hypovitamino-
sis D may be a vascular risk factor ( 33 ). It has been found 
among 318 older adults (mean age 74 years; 72.6% women) 
that subjects with hypovitaminosis D presented with more 
brain white matter hyperintensities ( p  <  .01) and more vessel 
infarcts ( p  <  .01) than controls ( 5 ). Inconsistencies with our 
study should be explained by the fact that non-AD dementias 
in our study could not be summed up with vascular dementias 
but also included neurosurgical or metabolic mechanisms 
that have no known relationship with vitamin D status. 
 Some limitations of this study need to be considered. 
First, the cohort was restricted to well-functioning women 
who might have easy access to vitamin D – rich foods and 
who might be unrepresentative of the general population of 
older adults. For instance, the mean dietary vitamin D intake of 
58.4  ±  30.1  μ g/wk (range: 2.5 – 205.5) reported in our study 
was relatively high compared  with previous studies reporting a 
mean intake around 40  μ g/wk in older adults with extremes 
values reaching 600  μ g/wk ( 34 , 35 ). Second, limitations of 
the study include the unavailability of a date of diagnosis of 
dementia and the lack of specifi c diagnosis of vascular demen-
tia within the group of OD. Third, an additional limitation 
lied in the self-administration of the food frequency question-
naire that might expose cognitively impaired participants to 
provide unreliable and invalid dietary data ( 20 ). However, 
the exclusion of 74 women with cognitive impairment at 
baseline (ie, SPMSQ score  <  8 ( 22 )) did not alter the mean-
ing and signifi cance of our results (data not shown), revealing 
that the measure of vitamin D dietary intakes was robust. 
Fourth, the interpretation of our results should also account 
for the high percentage of lost to follow-up that reached one 
in two in our study. Finally, in order to provide complemen-
tary information to the growing number of studies examin-
ing the association of serum 25-hydroxyvitamin D (25(OH)
D) concentration with cognitive function ( 2 – 7 ), we chose to 
examine instead the dietary intake of vitamin D, even if it is 
not the only contributor to 25(OH)D concentration. To limit 
confounding bias ( 36 ), we took into account other variables 
participating in 25(OH)D status such as sun exposure, season, 
 body mass index, or age ( 1 ). However residual potential 
confounders, including the variables changes during follow-
up, might still be present. Clinical trials are now warranted 
to explore the effect of vitamin D supplements on AD. 
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